FR2378024A1 - NEW SUBSTITUTED PROPYLAMINE, OBTAINING AND APPLYING - Google Patents

NEW SUBSTITUTED PROPYLAMINE, OBTAINING AND APPLYING

Info

Publication number
FR2378024A1
FR2378024A1 FR7702058A FR7702058A FR2378024A1 FR 2378024 A1 FR2378024 A1 FR 2378024A1 FR 7702058 A FR7702058 A FR 7702058A FR 7702058 A FR7702058 A FR 7702058A FR 2378024 A1 FR2378024 A1 FR 2378024A1
Authority
FR
France
Prior art keywords
obtaining
applying
new substituted
propylamine
substituted propylamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7702058A
Other languages
French (fr)
Other versions
FR2378024B1 (en
Inventor
R Y Mauvernay
N Busch
J Simond
A Monteil
J Moleyre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Europeen de Recherches Mauvernay CERM
Original Assignee
Centre Europeen de Recherches Mauvernay CERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Europeen de Recherches Mauvernay CERM filed Critical Centre Europeen de Recherches Mauvernay CERM
Priority to FR7702058A priority Critical patent/FR2378024A1/en
Priority to JP11797777A priority patent/JPS5392764A/en
Priority to CH27378A priority patent/CH628889A5/en
Priority to GB1506/78A priority patent/GB1595031A/en
Priority to IL53816A priority patent/IL53816A0/en
Priority to GR55207A priority patent/GR64868B7/en
Priority to PT67556A priority patent/PT67556B/en
Priority to NLAANVRAGE7800753,A priority patent/NL189258C/en
Priority to ES466237A priority patent/ES466237A1/en
Priority to AU32660/78A priority patent/AU516479B2/en
Priority to BE184554A priority patent/BE863214A/en
Priority to ZA00780426A priority patent/ZA78426B/en
Priority to DE2802864A priority patent/DE2802864C2/en
Publication of FR2378024A1 publication Critical patent/FR2378024A1/en
Application granted granted Critical
Publication of FR2378024B1 publication Critical patent/FR2378024B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

3-isobutoxy 2-pyrrolidino N-phényl N-benzyl propylamine. Ce composé présente une masse moléculaire M de 366 et un point d'ébullition E0 3 de 192 degrés C. Application au traitement des affections cardiovasculaires, notamment au traitement de l'angor.3-isobutoxy 2-pyrrolidino N-phenyl N-benzyl propylamine. This compound has a molecular mass M of 366 and a boiling point E0 3 of 192 degrees C. Application to the treatment of cardiovascular disorders, in particular to the treatment of angina.

FR7702058A 1973-02-28 1977-01-25 NEW SUBSTITUTED PROPYLAMINE, OBTAINING AND APPLYING Granted FR2378024A1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR7702058A FR2378024A1 (en) 1977-01-25 1977-01-25 NEW SUBSTITUTED PROPYLAMINE, OBTAINING AND APPLYING
JP11797777A JPS5392764A (en) 1977-01-25 1977-10-03 Novel substituted propylamine and method for its production
CH27378A CH628889A5 (en) 1977-01-25 1978-01-11 Substituted propylamine, process for its preparation and pharmaceutical composition containing this compound
GB1506/78A GB1595031A (en) 1977-01-25 1978-01-13 3-isobutoxy-2-pyrrolidino-n-phenyl-n-benzyl propylamine and its salts
IL53816A IL53816A0 (en) 1977-01-25 1978-01-16 A new substituted propylamine, its preparation and pharmaceutical compositions containing it
GR55207A GR64868B7 (en) 1973-02-28 1978-01-19 Method for the preparation of novel substituted propilamine
PT67556A PT67556B (en) 1977-01-25 1978-01-20 PROCESS FOR OBTAINING A NEW SUBSTITUTED PROPYLAMINE
NLAANVRAGE7800753,A NL189258C (en) 1977-01-25 1978-01-20 SALT OF 3-ISOBUTOXY-2-PYRROLIDINO-N-PHENYL-N-BENZYL-PROPYLAMINE WITH CARDIOVASCULAR PROPERTIES, AND THE MEDICINAL PRODUCT CONTAINING THIS SALT.
ES466237A ES466237A1 (en) 1977-01-25 1978-01-21 3-isobutoxy-2-pyrrolidino-n-phenyl-n-benzyl propylamine and its salts
AU32660/78A AU516479B2 (en) 1977-01-25 1978-01-23 Process for preparing 3-isobutoxy 2-pyrrolidino n-phenyl n-benzyl propylamine
BE184554A BE863214A (en) 1977-01-25 1978-01-23 NEW SUBSTITUTED PROPYLAMINE, OBTAINING AND APPLYING
ZA00780426A ZA78426B (en) 1977-01-25 1978-01-24 Substituted propylamine and a process for obtaining same
DE2802864A DE2802864C2 (en) 1977-01-25 1978-01-24 Process for the preparation of 3-isobutoxy-2-pyrrolidino-N-phenyl-N-benzylpropylamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7702058A FR2378024A1 (en) 1977-01-25 1977-01-25 NEW SUBSTITUTED PROPYLAMINE, OBTAINING AND APPLYING

Publications (2)

Publication Number Publication Date
FR2378024A1 true FR2378024A1 (en) 1978-08-18
FR2378024B1 FR2378024B1 (en) 1979-05-11

Family

ID=9185890

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7702058A Granted FR2378024A1 (en) 1973-02-28 1977-01-25 NEW SUBSTITUTED PROPYLAMINE, OBTAINING AND APPLYING

Country Status (12)

Country Link
JP (1) JPS5392764A (en)
AU (1) AU516479B2 (en)
BE (1) BE863214A (en)
CH (1) CH628889A5 (en)
DE (1) DE2802864C2 (en)
ES (1) ES466237A1 (en)
FR (1) FR2378024A1 (en)
GB (1) GB1595031A (en)
IL (1) IL53816A0 (en)
NL (1) NL189258C (en)
PT (1) PT67556B (en)
ZA (1) ZA78426B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138684A3 (en) * 1983-09-27 1985-06-19 Riom Laboratoires- C.E.R.M. "R.L.-Cerm" - (S.A.) 2-(n-pyrrolidino)-3-isobutoxy-n-phenyl-substituted n-benzylpropyl amines, their preparation and their pharmaceutical use
FR2558160A1 (en) * 1984-01-18 1985-07-19 Cerm Cent Europ Rech Mauvernay 3-ALKOXY 2- (N-PYRROLIDINO) -N-PYRIMIDINYL OR -PYRAZINYL PROPYLAMINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2558161A1 (en) * 1984-01-18 1985-07-19 Cerm Cent Europ Rech Mauvernay 3-ALKOXY 2- (N-PYRROLIDINO) N-FURYLMETHYL OR N-THIENYLMETHYL N-PYRIDYL PROPYLAMINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2558159A1 (en) * 1984-01-18 1985-07-19 Cerm Cent Europ Rech Mauvernay 3-Alkoxy-2-(N-pyrrolidino)-N-pyridyl-N-arylmethylpropylamines, their preparation and their therapeutic use
EP0303181A3 (en) * 1987-08-11 1991-09-04 Roche Diagnostics GmbH 1,2-diamine compounds, process for their preparation as well as medicaments containing these compounds

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE32715T1 (en) * 1981-12-28 1988-03-15 Carter Wallace PROCESS FOR THE PREPARATION OF B-((2METHYLPROPOXY)-METHYL>-N-PHENYL-N-(PHENYLMETHYL - 1-PYRROLIDINETHANAMINE.
EP0146159B1 (en) * 1983-11-11 1988-01-13 Akzo N.V. Ether of n-propanolamine derivative
GB8330197D0 (en) * 1983-11-11 1983-12-21 Akzo Nv Ether of n-propanolamine derivative
DE3726633A1 (en) * 1987-08-11 1989-02-23 Boehringer Mannheim Gmbh NEW 1,2-DIAMINO COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
JP2678758B2 (en) * 1988-02-16 1997-11-17 興和株式会社 Novel propane derivative
WO2016098128A1 (en) * 2014-12-16 2016-06-23 Council Of Scientific & Industrial Research Process for the preparation of bepridil

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2174655A1 (en) * 1972-03-06 1973-10-19 Mauvernay Ctre Rech

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2174655A1 (en) * 1972-03-06 1973-10-19 Mauvernay Ctre Rech

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0138684A3 (en) * 1983-09-27 1985-06-19 Riom Laboratoires- C.E.R.M. "R.L.-Cerm" - (S.A.) 2-(n-pyrrolidino)-3-isobutoxy-n-phenyl-substituted n-benzylpropyl amines, their preparation and their pharmaceutical use
FR2558160A1 (en) * 1984-01-18 1985-07-19 Cerm Cent Europ Rech Mauvernay 3-ALKOXY 2- (N-PYRROLIDINO) -N-PYRIMIDINYL OR -PYRAZINYL PROPYLAMINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2558161A1 (en) * 1984-01-18 1985-07-19 Cerm Cent Europ Rech Mauvernay 3-ALKOXY 2- (N-PYRROLIDINO) N-FURYLMETHYL OR N-THIENYLMETHYL N-PYRIDYL PROPYLAMINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2558159A1 (en) * 1984-01-18 1985-07-19 Cerm Cent Europ Rech Mauvernay 3-Alkoxy-2-(N-pyrrolidino)-N-pyridyl-N-arylmethylpropylamines, their preparation and their therapeutic use
EP0149583A3 (en) * 1984-01-18 1985-08-07 Riom Laboratoires- C.E.R.M. "R.L.-Cerm" - (S.A.) 3-alcoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(or thienyl)-methyl propyl amines, their preparation and pharmaceutical compositions containing them
EP0151062A3 (en) * 1984-01-18 1985-08-21 Riom Laboratoires- C.E.R.M. "R.L.-Cerm" - (S.A.) 3-alkoxy-2-(n-pyrrolidino)-n-pyrimidinyl or n-pyrazinylpropylamines, their preparation and pharmaceutical compositions containing them
EP0303181A3 (en) * 1987-08-11 1991-09-04 Roche Diagnostics GmbH 1,2-diamine compounds, process for their preparation as well as medicaments containing these compounds

Also Published As

Publication number Publication date
ZA78426B (en) 1979-01-31
AU3266078A (en) 1979-08-02
DE2802864C2 (en) 1982-12-09
CH628889A5 (en) 1982-03-31
NL189258C (en) 1993-02-16
NL7800753A (en) 1978-07-27
NL189258B (en) 1992-09-16
BE863214A (en) 1978-07-24
GB1595031A (en) 1981-08-05
PT67556B (en) 1979-06-18
PT67556A (en) 1978-02-01
AU516479B2 (en) 1981-06-04
JPS5429493B2 (en) 1979-09-25
DE2802864A1 (en) 1978-07-27
FR2378024B1 (en) 1979-05-11
IL53816A0 (en) 1978-04-30
JPS5392764A (en) 1978-08-15
ES466237A1 (en) 1978-10-16

Similar Documents

Publication Publication Date Title
FR2378024A1 (en) NEW SUBSTITUTED PROPYLAMINE, OBTAINING AND APPLYING
BE869356Q (en) NEW COMPOSITIONS OF MONOMERS, THEIR PREPARATION AND THEIR APPLICATION, ESPECIALLY FOR THE COATING AND IMPREGNATION OF SUBSTRATES
FR2361385A1 (en) NEW QUINAZOLINONES, THEIR METHODS OF OBTAINING AND THEIR APPLICATION TO THERAPEUTICS
IT7820500A0 (en) ANALGESIC, ANTI-INFLAMMATION PHARMACEUTICAL COMPOSITIONS WITH AND INHIBITORS OF PROSTAGLANDIN SYNTHETASE
BE604074A (en) Electrodes containing compounds of silver and cadmium.
ES8101624A1 (en) Spiroketalins and their applications
BE846981A (en) NEW N-SUBSTITUTED ACRYLAMIDINES, COPOLYMERS OF N-SUBSTITUTED ACRYLAMIDINES AND ACRYLIC AND METHACRYLIC ACID ESTERS AND APPLICATIONS OF SUCH COPOLYMERS
BG29646A2 (en) 1,3-DISUBSTITUTED UREAS AND 2-THIOCUREAS, METHOD FOR THEIR PREPARATION AND THEIR APPLICATION
FR2433019A1 (en) NOVEL THIOPHENECARBOXAMIDOALKYLMERCAPTANS, USEFUL IN PARTICULAR AS MUCOLYTICS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR1302320A (en) Modified polymers of 1,2-epoxyhydrocarbons and their preparation
JPS52129355A (en) Amplifier
IT7949251A0 (en) IMPROVEMENT IN COMPOSITIONS FOR THE PREVENTION OF DENTAL CARIES
IT1089008B (en) PRODUCTION PROCESS OF ALUMINUM OXIDE CONTAINING FROM 0.01% TO 25% OF CHROMIUM OXIDE AND / OR IRON OXIDE
PT67885B (en) TICS, IN PARTICULAR FOR THE TREATMENT OF FUNCULAR DISORDERS
BE888963A (en) CARDIOTONIC COMPOSITIONS CONTAINING AMINOPHENYLPYRIDINES, NOVEL AMINOPHENYLPYRIDINES AND THEIR PREPARATION
FR1436593A (en) Coating compositions containing oxychloropolyethylene and process for obtaining them
JPS5210881A (en) Fluorescent substances
FR2415108A1 (en) NEW LACTONIC COMPOUNDS AND THEIR APPLICATION IN PERFUMERY
FR2429207A1 (en) (1-ALKYL-5-NITRO-2-IMIDAZOLYL) -VINYL-GLYOXAL-DIACETALS, LYL) -VINYL-GLYOXAL-CIACETALS, THEIR OBTAINMENT AND THEIR USE
SU582231A1 (en) Ceramic compound
FR2401164A1 (en) NEW THIENO-OXAZINES AND ANTI-ALLERGIC MEDICINAL PRODUCT CONTAINING THEM
BG45044A3 (en) METHOD FOR OBTAINING CONDENSED AS-TRIAZINES
SU997415A1 (en) 1,3-Dimethyl-6-hydrazinouracil hydrazones exhibiting analgesic activity
FR2319678A1 (en) DISPERSABLE MONOAZOIC COLORANTS DERIVED FROM SULFAMOYL-ANILINE, THEIR OBTAINING AND THEIR APPLICATION
SU869293A1 (en) Mono-, di- and trisubstituted (1-hexylmethoxy) phenylsilanes exhibiting anti-inflammatory activity

Legal Events

Date Code Title Description
CD Change of name or company name